QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $22,015 | $17,087 | $13,267 | $9,324 |
| - Cash | $1,386 | $447 | $390 | $851 |
| + Debt | $8 | $8 | $8 | $8 |
| Enterprise Value | $20,636 | $16,648 | $12,885 | $8,480 |
| Revenue | $1,099 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$275 | -$274 | $0 |
| % Margin | 0% | – | – | – |
| EBITDA | -$436 | -$1,159 | -$1,116 | -$1,033 |
| % Margin | -39.7% | – | – | – |
| Net Income | -$484 | -$1,164 | -$1,238 | -$1,507 |
| % Margin | -44% | – | – | – |
| EPS Diluted | -0.13 | -0.36 | -0.43 | -0.9 |
| % Growth | 63.9% | 16.3% | 52.2% | – |
| Operating Cash Flow | -$1,160 | -$443 | -$804 | -$440 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,160 | -$443 | -$804 | -$440 |